Please assess the completion status of the following clinical trial:

Trial Title: High Cut-Off Continuous Veno-venous Hemodialysis (CVVHD) in Patients Treated for Acute Renal Failure After Systemic Inflammatory Response Syndrome (SIRS)/Septic Shock

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Fulfilling at least two of the SIRS criteria as defined by the American College of Chest Physicians (ACCP)/Society of Critical Care Medicine (SCCM) Consensus Conference~2. Having signs of renal dysfunction~3. Requirement for catecholamine administration (norepinephrine or others)~4. Acute Physiology And Chronic Health Evaluation (APACHE II) score at enrolment greater than or equal to 19 and less than or equal to 30~Exclusion Criteria:~1. Lack of written informed consent from patients or a legally authorized surrogate~2. Duration of septic shock greater than 4 days~3. Hypoproteinemia (characterized by serum albumin less than 18 g/l)~4. End stage renal failure~5. Known active malignancy~6. Known human immunodeficiency virus (HIV), hepatitis B virus (HBV) or hepatitis C virus (HCV) infection~7. Age younger than 18 years or older than 80 years~8. Known pregnancy~9. Immunosuppression after transplantation~10. Participation in another clinical study~11. Renal replacement therapy greater than 24 hours before randomization

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- HCO (Type: EXPERIMENTAL): High cut-off filters HCO1100
- control (Type: ACTIVE_COMPARATOR): conventional high-flux filters

Based on this trial design, predict the completion outcome and termination type (if applicable).